VOR
Vor Biopharma Inc. · Healthcare · Biotechnology
Momentum inputs (comparable managers):
holder breadth +10.0% ·
share flow -30.0% ·
net new positions +9.1%
— formula
Ownership fragmentation — more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 46 | +15 | 17.25M | $317.51M | +16 | −1 |
| Q1 2026 | 31 | +7 | 8.52M | $152.06M | +8 | −1 |
| Q4 2025 | 24 | -1 | 5.67M | $74.16M | — | −1 |
| Q3 2025 | 11 | +1 | 478.12K | $23.29M | +2 | −1 |
| Q2 2025 | 7 | -2 | 5.57M | $9.03M | — | −2 |
| Q1 2025 | 6 | -1 | 1.58M | $1.14M | — | −1 |
| Q4 2024 | 7 | 0 | 1.73M | $1.92M | — | — |
| Q3 2024 | 6 | 0 | 1.74M | $1.22M | +1 | −1 |
| Q2 2024 | 6 | — | 1.49M | $1.49M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 236.51K | +126.0% | $11.52M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passive) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (passive) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passive) | 105.19K | +9.8% | $5.12M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 34.53K | +84.3% | $1.68M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 27.39K | +25.8% | $1.33M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 11 | Millennium Management ✦ | 24.76K | New | $1.21M | 0.0% | New | 1 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Goldman Sachs Group ✦ | 15.79K | — | $769,094 | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Renaissance Technologies ✦ | 14.60K | -37.6% | $711,312 | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 15 | State Street Global Advisors ✦ (passive) | 9.05K | +56.2% | $441,111 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 5.69K | New | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 5.69K | New | $277,022 | 0.0% | New | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 4.46K | — | $217,096 | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 156 | — | $7,600 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Millennium Management | $1.21M | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
| Citadel Advisors | $277,022 | 0.0% |
Exited
| Two Sigma Investments | $274,810 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 79 holders, 40.44M shares, $716.36M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.